Oligodendroglioma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Sara Mohsin (talk | contribs) |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oligodendroglioma}} | {{Oligodendroglioma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{S.M.}}{{SR}} | ||
==Overview== | ==Overview== | ||
There is no established system for the staging of oligodendroglioma. | There is no established [[system]] for the [[Staging (pathology)|staging]] of [[oligodendroglioma]]. | ||
==Staging== | ==Staging== | ||
There is no established system for the staging of oligodendroglioma. | There is no established [[system]] for the [[Staging (pathology)|staging]] of [[oligodendroglioma]]. | ||
==References== | ==References== | ||
Line 20: | Line 20: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 04:30, 17 May 2019
Oligodendroglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oligodendroglioma staging On the Web |
American Roentgen Ray Society Images of Oligodendroglioma staging |
Risk calculators and risk factors for Oligodendroglioma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]
Overview
There is no established system for the staging of oligodendroglioma.
Staging
There is no established system for the staging of oligodendroglioma.